Quick Answer
CHINA PHARMA HOLDINGS, INC. reported Gross Profit of -$1.99 million for fiscal year 2024.
CHINA PHARMA HOLDINGS, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | -$1.99M | -606.4% |
| 2023 | -$281.1K | +43.1% |
| 2022 | -$493.9K | -241.4% |
| 2021 | $349.3K | -82.1% |
| 2020 | $1.95M | +31.8% |
| 2019 | $1.48M | -24.9% |
| 2018 | $1.97M | -20.0% |
| 2017 | $2.47M | -23.3% |
| 2016 | $3.22M | +119.8% |
| 2015 | $1.46M | -73.2% |
| 2014 | $5.46M | +1235.7% |
| 2013 | -$480.9K | -103.4% |
| 2012 | $14.08M | -51.4% |
| 2011 | $28.99M | -4.3% |
| 2010 | $30.28M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$59.7K | +88.5% | +31.4% |
| June 30, 2025 | -$87.0K | +91.4% | +36.1% |
| March 31, 2025 | -$136.1K | +53.1% | +73.8% |
| September 30, 2024 | -$519.6K | -122.8% | +48.8% |
| June 30, 2024 | -$1.02M | -592.3% | -250.1% |
| March 31, 2024 | -$290.0K | -263.0% | -24.4% |
| September 30, 2023 | -$233.2K | -69.3% | -59.0% |
| June 30, 2023 | -$146.7K | +36.1% | -182.4% |
- CHINA PHARMA HOLDINGS, INC. showed a decrease of -606.4% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2024 period, CHINA PHARMA HOLDINGS, INC.’s gross profit has declined by 106.6% (from $30.28 million to -$1.99 million).
- The most recent figure is from CHINA PHARMA HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: